Advanced glycation end products (AGEs), involved in the pathogenesis of diabetic complications, comprise a series of related chemical structures which might possess dissimilar immunogenic characteristics. In this study the levels of AGE in plasma samples from normal subjects (N/41) and diabetic patients (N/44) were measured by ELISA using two polyclonal antisera (named CF5 and CF199, respectively, and immunologically characterized) raised using two different immunogens and immunization techniques. Age levels were significantly higher in diabetic than in normal plasma samples (PB/0.0001) with both antisera. However, CF199 detected higher AGE levels than CF5 both in normal (PB/0.0001) and diabetic (PB/0.005) samples. Pre-incubation with AGE/ bovine serum albumin (BSA) caused the loss of most the reactivity of both antisera. Pre-incubation with carboxy-methyl-lysine/ BSA (an oxidation-derived AGE) induced the loss of nearly all CF5 reactivity while CF199 retained a significant amount of activity against AGE antigens. Moreover, CF5 lost over 90% of its reactivity against BSA incubated with high glucose under non-oxidative conditions, suggesting its recognition of mainly oxidation-derived AGE epitopes. The different AGE levels measured by the two antisera suggests, therefore, that one single antiserum is unable to recognize all the various AGE epitopes which might be present, at any time, in tissues and body fluids in health and disease.
Two polyclonal antisera detect different AGE epitopes in human plasma samples / A. M., Bongiorno; E., Sagratella; S., Morelli; O. J., Bjerrum; E., Maroccia; Morano, Susanna; Fallucca, Francesco; DI MARIO, Umberto; Sensi, Maurizio. - In: IMMUNOLOGY LETTERS. - ISSN 0165-2478. - 85:3(2003), pp. 243-249. [10.1016/s0165-2478(02)00242-0]
Two polyclonal antisera detect different AGE epitopes in human plasma samples
MORANO, Susanna;FALLUCCA, Francesco;DI MARIO, Umberto;SENSI, Maurizio
2003
Abstract
Advanced glycation end products (AGEs), involved in the pathogenesis of diabetic complications, comprise a series of related chemical structures which might possess dissimilar immunogenic characteristics. In this study the levels of AGE in plasma samples from normal subjects (N/41) and diabetic patients (N/44) were measured by ELISA using two polyclonal antisera (named CF5 and CF199, respectively, and immunologically characterized) raised using two different immunogens and immunization techniques. Age levels were significantly higher in diabetic than in normal plasma samples (PB/0.0001) with both antisera. However, CF199 detected higher AGE levels than CF5 both in normal (PB/0.0001) and diabetic (PB/0.005) samples. Pre-incubation with AGE/ bovine serum albumin (BSA) caused the loss of most the reactivity of both antisera. Pre-incubation with carboxy-methyl-lysine/ BSA (an oxidation-derived AGE) induced the loss of nearly all CF5 reactivity while CF199 retained a significant amount of activity against AGE antigens. Moreover, CF5 lost over 90% of its reactivity against BSA incubated with high glucose under non-oxidative conditions, suggesting its recognition of mainly oxidation-derived AGE epitopes. The different AGE levels measured by the two antisera suggests, therefore, that one single antiserum is unable to recognize all the various AGE epitopes which might be present, at any time, in tissues and body fluids in health and disease.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
